South Korean President Moon Jae-in is in the United States this week. And while his travel plans focused heavily on the United Nations General Assembly, Korean media reported Moon’s approach and included a meeting with Pfizer’s chief executive, Albert Bourlar. It could be one of the world’s leading suppliers of COVID-19 vaccines.
In May 2021, Moon and US President Biden signed a joint agreement between the two countries to develop a vaccine. Details are expected to be revealed this week, with Moon attending a singing show. In any case, the partnership is at the heart of a $2 billion investment plan designed to position South Korea as the largest vaccine production center in Asia.
JOIN SAMSUNG ON TELEGRAM
South Korea wants to be the leading producer of vaccines
Amazingly, Samsung is designed to play a key role in this R&D process. And in this case, “Samsung” refers to Samsung Biologics, a unit of Songdo in Samsung Group’s Incheon-based biotechnology company. According to the report, the Korean side of the agreement also includes SK Bioscience’s production capabilities.
The government recently unveiled a new 2.2 trillion won ($1.92 billion) plan to invest in the development and production of a vaccine over the next five years, with the aim of achieving its first locally-grown COVID-19 vaccine in the first half of next year. 19 The vaccine has to debut and become one. Among the top five vaccine producers by 2025.
In addition to making vaccines, Chaebol has also played a role in resisting the global pandemic. For example, it was introduced just last month that how Samsung Pay users can store their digital vaccination credentials on their devices. The feature, built next to the Commons Project Foundation, debuted worldwide in early September.
But to get the most out of it, you need to be a CommonHealth user. And judging by the latest Play Store update, many are still struggling to get it working.
